Evidence map›Paper›PMID 39185537›Full record

ArticlemedRxiv : the preprint server for health sciences2024

Atika FArzana Urmi, Chenlu Ke, Dipankar Bandyopadhyay

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Updated by
    2025
5 · Who and what money

Authors and funding

3 authors.

Atika FArzana UrmiDepartment of Biostatistics Virginia Commonwealth University VA, USA.
Chenlu KeDepartment of Statistical Sciences and Operations Research Virginia Commonwealth University VA, USA.
Dipankar BandyopadhyayDepartment of Biostatistics Virginia Commonwealth University VA, USA.

Funding

Virus Vector Shared ResourceP30CA016059 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI Keri R Maher · 1985 to 2026
$51.0M
Translational Research Center in Lung Cancer Disparities (TRACER)P20CA252717 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI SEEWALDT, VICTORIA L. · 2021 to 2023
$3.2M
SUCCEED Cancer Research Education Program (CREP)P20CA264067 · NCI · VIRGINIA COMMONWEALTH UNIVERSITY · PI WINN, ROBERT A. · 2021 to 2024
$845k
A pragmatic risk index evaluating the elderly with comorbidity for oral health event timesR21DE031879 · NIDCR · VIRGINIA COMMONWEALTH UNIVERSITY · PI BANDYOPADHYAY, DIPANKAR · 2022 to 2023
$446k
NCI NIH HHS P20 CA252717NCI NIH HHS P20 CA264067NCI NIH HHS P30 CA016059NIDCR NIH HHS R21 DE031879
6 · The paper itself

Abstract

Recent advances in sequencing technologies have allowed collection of massive genome-wide information that substantially enhances the diagnosis and prognosis of head and neck cancer. Identifying predictive markers for survival time is crucial for devising prognostic systems, and learning the underlying molecular driver of the cancer course. In this paper, we introduce

Indexed as

FDR controlfeature screeninghead and neck cancerhigh dimensional covariatesnonparametricright-censoring

Identifiers

PMID39185537
PMCPMC11343256

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.